For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago

For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago

Source: 
Xconomy
snippet: 

For Justin Gover, CEO of British drugmaker GW Pharmaceuticals (NASDAQ: GWPH), society’s sudden embrace of cannabidiol (CBD), the other active ingredient found in the cannabis plant, is a trip—though CBD won’t make you trip. That’s caused by THC, or tetrahydrocannabinol, the cannabis component responsible for most of marijuana’s psychological effects.